Selected research
Market Structure
Global Arteriovenous Fistula (AVF) Needle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Arteriovenous Fistula (AVF) Needle market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Arteriovenous Fistula (AVF) Needle include B. Braun, Fresenius, Nipro, JMS, Kawasumi Lab, NxStage Medical, Asahi Kasei, Beldico and Farmasol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Arteriovenous Fistula (AVF) Needle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Arteriovenous Fistula (AVF) Needle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Arteriovenous Fistula (AVF) Needle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arteriovenous Fistula (AVF) Needle market size, projected growth trends, production technologies, key applications, and end-use industries.
Arteriovenous Fistula (AVF) Needle Segment by Company
B. Braun
Fresenius
Nipro
JMS
Kawasumi Lab
NxStage Medical
Asahi Kasei
Beldico
Farmasol
Hemoclean
Bain Medical
Tianjin Pharma
Hongda Medical
Baihe Medical
Dalian Aohua Medical Polymer Equipment
Sansin Medical
Zhejiang Kindly Medical Devices
Ningbo Tianyi Medical Appliance
Arteriovenous Fistula (AVF) Needle Segment by Type
15G
16G
17G
18G
Others
Arteriovenous Fistula (AVF) Needle Segment by Application
Hospital
Clinic
Dialysis Center
Arteriovenous Fistula (AVF) Needle Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arteriovenous Fistula (AVF) Needle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arteriovenous Fistula (AVF) Needle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arteriovenous Fistula (AVF) Needle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Arteriovenous Fistula (AVF) Needle market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arteriovenous Fistula (AVF) Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Arteriovenous Fistula (AVF) Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Arteriovenous Fistula (AVF) Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 15G
- 16G
- 17G
- 18G
- Others
Applications
- Hospital
- Clinic
- Dialysis Center
Companies covered
- B. Braun
- Fresenius
- Nipro
- JMS
- Kawasumi Lab
- NxStage Medical
- Asahi Kasei
- Beldico
- Farmasol
- Hemoclean
- Bain Medical
- Tianjin Pharma
- Hongda Medical
- Baihe Medical
- Dalian Aohua Medical Polymer Equipment
- Sansin Medical
- Zhejiang Kindly Medical Devices
- Ningbo Tianyi Medical Appliance
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Arteriovenous Fistula (AVF) Needle Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Arteriovenous Fistula (AVF) Needle Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Arteriovenous Fistula (AVF) Needle Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Arteriovenous Fistula (AVF) Needle Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Arteriovenous Fistula (AVF) Needle Market Dynamics
- 2.1 Arteriovenous Fistula (AVF) Needle Industry Trends
- 2.2 Arteriovenous Fistula (AVF) Needle Industry Drivers
- 2.3 Arteriovenous Fistula (AVF) Needle Industry Opportunities and Challenges
- 2.4 Arteriovenous Fistula (AVF) Needle Industry Restraints
3 Arteriovenous Fistula (AVF) Needle Market by Manufacturers
- 3.1 Global Arteriovenous Fistula (AVF) Needle Revenue by Manufacturers (2021-2026)
- 3.2 Global Arteriovenous Fistula (AVF) Needle Sales by Manufacturers (2021-2026)
- 3.3 Global Arteriovenous Fistula (AVF) Needle Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Arteriovenous Fistula (AVF) Needle Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Arteriovenous Fistula (AVF) Needle Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Arteriovenous Fistula (AVF) Needle Manufacturers, Product Type & Application
- 3.7 Global Arteriovenous Fistula (AVF) Needle Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Arteriovenous Fistula (AVF) Needle Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Arteriovenous Fistula (AVF) Needle Players Market Share by Revenue in 2025
- 3.8.3 2025 Arteriovenous Fistula (AVF) Needle Tier 1, Tier 2, and Tier 3
4 Arteriovenous Fistula (AVF) Needle Market by Type
- 4.1 Arteriovenous Fistula (AVF) Needle Type Introduction
- 4.1.1 15G
- 4.1.2 16G
- 4.1.3 17G
- 4.1.4 18G
- 4.1.5 Others
- 4.2 Global Arteriovenous Fistula (AVF) Needle Sales by Type
- 4.2.1 Global Arteriovenous Fistula (AVF) Needle Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Arteriovenous Fistula (AVF) Needle Sales by Type (2021-2032)
- 4.2.3 Global Arteriovenous Fistula (AVF) Needle Sales Market Share by Type (2021-2032)
- 4.3 Global Arteriovenous Fistula (AVF) Needle Revenue by Type
- 4.3.1 Global Arteriovenous Fistula (AVF) Needle Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Arteriovenous Fistula (AVF) Needle Revenue by Type (2021-2032)
- 4.3.3 Global Arteriovenous Fistula (AVF) Needle Revenue Market Share by Type (2021-2032)
5 Arteriovenous Fistula (AVF) Needle Market by Application
- 5.1 Arteriovenous Fistula (AVF) Needle Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Dialysis Center
- 5.2 Global Arteriovenous Fistula (AVF) Needle Sales by Application
- 5.2.1 Global Arteriovenous Fistula (AVF) Needle Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Arteriovenous Fistula (AVF) Needle Sales by Application (2021-2032)
- 5.2.3 Global Arteriovenous Fistula (AVF) Needle Sales Market Share by Application (2021-2032)
- 5.3 Global Arteriovenous Fistula (AVF) Needle Revenue by Application
- 5.3.1 Global Arteriovenous Fistula (AVF) Needle Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Arteriovenous Fistula (AVF) Needle Revenue by Application (2021-2032)
- 5.3.3 Global Arteriovenous Fistula (AVF) Needle Revenue Market Share by Application (2021-2032)
6 Global Arteriovenous Fistula (AVF) Needle Sales by Region
- 6.1 Global Arteriovenous Fistula (AVF) Needle Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Arteriovenous Fistula (AVF) Needle Sales by Region (2021-2032)
- 6.2.1 Global Arteriovenous Fistula (AVF) Needle Sales by Region (2021-2026)
- 6.2.2 Global Arteriovenous Fistula (AVF) Needle Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Arteriovenous Fistula (AVF) Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Arteriovenous Fistula (AVF) Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Arteriovenous Fistula (AVF) Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Arteriovenous Fistula (AVF) Needle Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Arteriovenous Fistula (AVF) Needle Revenue by Region
- 7.1 Global Arteriovenous Fistula (AVF) Needle Revenue by Region
- 7.1.1 Global Arteriovenous Fistula (AVF) Needle Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Arteriovenous Fistula (AVF) Needle Revenue by Region (2021-2026)
- 7.1.3 Global Arteriovenous Fistula (AVF) Needle Revenue by Region (2027-2032)
- 7.1.4 Global Arteriovenous Fistula (AVF) Needle Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Arteriovenous Fistula (AVF) Needle Revenue (2021-2032)
- 7.2.2 North America Arteriovenous Fistula (AVF) Needle Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Arteriovenous Fistula (AVF) Needle Revenue (2021-2032)
- 7.3.2 Europe Arteriovenous Fistula (AVF) Needle Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Arteriovenous Fistula (AVF) Needle Revenue (2021-2032)
- 7.4.2 Asia-Pacific Arteriovenous Fistula (AVF) Needle Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Arteriovenous Fistula (AVF) Needle Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Arteriovenous Fistula (AVF) Needle Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 B. Braun
- 8.1.1 B. Braun Company Information
- 8.1.2 B. Braun Business Overview
- 8.1.3 B. Braun Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 B. Braun Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.1.5 B. Braun Recent Developments
- 8.2 Fresenius
- 8.2.1 Fresenius Company Information
- 8.2.2 Fresenius Business Overview
- 8.2.3 Fresenius Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fresenius Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.2.5 Fresenius Recent Developments
- 8.3 Nipro
- 8.3.1 Nipro Company Information
- 8.3.2 Nipro Business Overview
- 8.3.3 Nipro Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nipro Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.3.5 Nipro Recent Developments
- 8.4 JMS
- 8.4.1 JMS Company Information
- 8.4.2 JMS Business Overview
- 8.4.3 JMS Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 JMS Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.4.5 JMS Recent Developments
- 8.5 Kawasumi Lab
- 8.5.1 Kawasumi Lab Company Information
- 8.5.2 Kawasumi Lab Business Overview
- 8.5.3 Kawasumi Lab Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Kawasumi Lab Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.5.5 Kawasumi Lab Recent Developments
- 8.6 NxStage Medical
- 8.6.1 NxStage Medical Company Information
- 8.6.2 NxStage Medical Business Overview
- 8.6.3 NxStage Medical Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 NxStage Medical Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.6.5 NxStage Medical Recent Developments
- 8.7 Asahi Kasei
- 8.7.1 Asahi Kasei Company Information
- 8.7.2 Asahi Kasei Business Overview
- 8.7.3 Asahi Kasei Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Asahi Kasei Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.7.5 Asahi Kasei Recent Developments
- 8.8 Beldico
- 8.8.1 Beldico Company Information
- 8.8.2 Beldico Business Overview
- 8.8.3 Beldico Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Beldico Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.8.5 Beldico Recent Developments
- 8.9 Farmasol
- 8.9.1 Farmasol Company Information
- 8.9.2 Farmasol Business Overview
- 8.9.3 Farmasol Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Farmasol Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.9.5 Farmasol Recent Developments
- 8.10 Hemoclean
- 8.10.1 Hemoclean Company Information
- 8.10.2 Hemoclean Business Overview
- 8.10.3 Hemoclean Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hemoclean Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.10.5 Hemoclean Recent Developments
- 8.11 Bain Medical
- 8.11.1 Bain Medical Company Information
- 8.11.2 Bain Medical Business Overview
- 8.11.3 Bain Medical Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bain Medical Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.11.5 Bain Medical Recent Developments
- 8.12 Tianjin Pharma
- 8.12.1 Tianjin Pharma Company Information
- 8.12.2 Tianjin Pharma Business Overview
- 8.12.3 Tianjin Pharma Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Tianjin Pharma Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.12.5 Tianjin Pharma Recent Developments
- 8.13 Hongda Medical
- 8.13.1 Hongda Medical Company Information
- 8.13.2 Hongda Medical Business Overview
- 8.13.3 Hongda Medical Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Hongda Medical Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.13.5 Hongda Medical Recent Developments
- 8.14 Baihe Medical
- 8.14.1 Baihe Medical Company Information
- 8.14.2 Baihe Medical Business Overview
- 8.14.3 Baihe Medical Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Baihe Medical Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.14.5 Baihe Medical Recent Developments
- 8.15 Dalian Aohua Medical Polymer Equipment
- 8.15.1 Dalian Aohua Medical Polymer Equipment Company Information
- 8.15.2 Dalian Aohua Medical Polymer Equipment Business Overview
- 8.15.3 Dalian Aohua Medical Polymer Equipment Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Dalian Aohua Medical Polymer Equipment Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.15.5 Dalian Aohua Medical Polymer Equipment Recent Developments
- 8.16 Sansin Medical
- 8.16.1 Sansin Medical Company Information
- 8.16.2 Sansin Medical Business Overview
- 8.16.3 Sansin Medical Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Sansin Medical Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.16.5 Sansin Medical Recent Developments
- 8.17 Zhejiang Kindly Medical Devices
- 8.17.1 Zhejiang Kindly Medical Devices Company Information
- 8.17.2 Zhejiang Kindly Medical Devices Business Overview
- 8.17.3 Zhejiang Kindly Medical Devices Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Zhejiang Kindly Medical Devices Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.17.5 Zhejiang Kindly Medical Devices Recent Developments
- 8.18 Ningbo Tianyi Medical Appliance
- 8.18.1 Ningbo Tianyi Medical Appliance Company Information
- 8.18.2 Ningbo Tianyi Medical Appliance Business Overview
- 8.18.3 Ningbo Tianyi Medical Appliance Arteriovenous Fistula (AVF) Needle Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Ningbo Tianyi Medical Appliance Arteriovenous Fistula (AVF) Needle Product Portfolio
- 8.18.5 Ningbo Tianyi Medical Appliance Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Arteriovenous Fistula (AVF) Needle Value Chain Analysis
- 9.1.1 Arteriovenous Fistula (AVF) Needle Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Arteriovenous Fistula (AVF) Needle Production Mode & Process
- 9.2 Arteriovenous Fistula (AVF) Needle Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Arteriovenous Fistula (AVF) Needle Distributors
- 9.2.3 Arteriovenous Fistula (AVF) Needle Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst